文献速递心脑血管急症重症综合管理与镇静镇痛

疑似非ST段抬高急性冠脉综合征患者院内的心脏骤停预测:SAFER评分

A user-friendly risk-score for predicting in-hospital cardiac arrest among patients admitted with suspected non ST-elevation acute coronary syndrome - The SAFER-score.
PubMed 文献 · Resuscitation · 2017-10-06
一句话结论SAFER评分(5变量7分)可预测疑似NSTE-ACS患者院内的心脏骤停,推导队列c统计量0.72,外部验证0.65。

基于SWEDEHEART登记库2008–2014年242303例疑似NSTE-ACS患者,用 logistic 回归从26个候选变量中建立SAFER评分:年龄≥60岁(1分)、ST-T异常(2分)、Killip分级>1(1分)、心率<50或≥100次/分(1分)、收缩压<100mmHg(2分)。推导队列c统计量0.72,时间验证队列0.74,外部验证(MINAP)0.65。评分在推导和时间验证中校准尚可但高分倾向高估风险,外部验证总体低估预测风险。该评分有助于入院时识别院内的心脏骤停高危患者。

要点

  • SAFER评分含5个入院即可获得的变量:年龄≥60岁(1分)、ST-T异常(2分)、Killip分级>1(1分)、心率<50或≥100次/分(1分)、收缩压<100mmHg(2分)。
  • 推导队列(SWEDEHEART 2008–2014,n=242303)c统计量0.72,时间验证队列(n=126073)0.74,外部验证(MINAP,n=276109)0.65。
  • 院内的心脏骤停发生率:SWEDEHEART推导队列NSTE-ACS为1.3%、非ACS为0.5%;MINAP为2.3%和2.3%。
  • 校准:推导和时间验证队列校准尚可但高分倾向高估风险;外部验证总体低估预测风险。
  • 该评分仅用于预测院内的心脏骤停风险,原文未给出基于评分的治疗或监护推荐。

适用人群与场景

  • 疑似非ST段抬高急性冠脉综合征(NSTE-ACS)住院患者。
  • 推导队列为SWEDEHEART登记库2008–2014年入院患者(n=242303);时间验证队列为SWEDEHEART 2005–2007年患者(n=126073);外部验证队列为MINAP 2008–2013年患者(n=276109)。

诊断标准与关键阈值

  • SAFER评分:年龄≥60岁(1分)、ST-T异常(2分)、Killip分级>1(1分)、心率<50或≥100次/分(1分)、收缩压<100mmHg(2分),总分7分。

研究设计与关键结果

  • 研究类型:基于登记库的评分推导与验证研究;推导队列n=242303(SWEDEHEART 2008–2014),时间验证队列n=126073(SWEDEHEART 2005–2007),外部验证队列n=276109(MINAP 2008–2013)。
  • 从26个候选变量中建立5变量7分SAFER评分。
  • 判别力:推导队列c统计量0.72,时间验证队列0.74,外部验证队列0.65。
  • 校准:推导和时间验证队列校准尚可,高分时倾向高估风险;外部验证总体低估预测风险。
  • 院内的心脏骤停发生率:SWEDEHEART推导队列NSTE-ACS 1.3%、非ACS 0.5%;MINAP NSTE-ACS 2.3%、非ACS 2.3%。

证据类型、等级与局限

  • 证据类型:基于登记库的评分推导与验证研究(非RCT)。
  • 局限:外部验证判别力中等(c统计量0.65);推导和时间验证队列高分时倾向高估风险,外部验证总体低估预测风险。

对床旁实践的改变

  • 对疑似NSTE-ACS住院患者,入院时可用SAFER评分(年龄≥60岁、ST-T异常、Killip分级>1、心率<50或≥100次/分、收缩压<100mmHg)评估院内的心脏骤停风险。
  • 原文未根据SAFER评分给出预防院内的心脏骤停的监护或治疗推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIM: To develop a simple risk-score model for predicting in-hospital cardiac arrest (CA) among patients hospitalized with suspected non-ST elevation acute coronary syndrome (NSTE-ACS).

METHODS: Using the Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART), we identified patients (n=242 303) admitted with suspected NSTE-ACS between 2008 and 2014. Logistic regression was used to assess the association between 26 candidate variables and in-hospital CA. A risk-score model was developed and validated using a temporal cohort (n=126 073) comprising patients from SWEDEHEART between 2005 and 2007 and an external cohort (n=276 109) comprising patients from the Myocardial Ischaemia National Audit Project (MINAP) between 2008 and 2013.

RESULTS: The incidence of in-hospital CA for NSTE-ACS and non-ACS was lower in the SWEDEHEART-derivation cohort than in MINAP (1.3% and 0.5% vs. 2.3% and 2.3%). A seven point, five variable risk score (age ≥60 years (1 point), ST-T abnormalities (2 points), Killip Class >1 (1 point), heart rate <50 or ≥100bpm (1 point), and systolic blood pressure <100mmHg (2 points) was developed. Model discrimination was good in the derivation cohort (c-statistic 0.72) and temporal validation cohort (c-statistic 0.74), and calibration was reasonable with a tendency towards overestimation of risk with a higher sum of score points. External validation showed moderate discrimination (c-statistic 0.65) and calibration showed a general underestimation of predicted risk.

CONCLUSIONS: A simple points score containing five variables readily available on admission predicts in-hospital CA for patients with suspected NSTE-ACS.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Faxén J, Hall M, Gale CP, et al. A user-friendly risk-score for predicting in-hospital cardiac arrest among patients admitted with suspected non ST-elevation acute coronary syndrome - The SAFER-score. Resuscitation. 2017. PMID: 28993178. doi:10.1016/j.resuscitation.2017.10.004

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。